Upstream Bio EBITDA Margin 1971-1970 | UPB

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Upstream Bio ebitda margin from 1971 to 1970. Ebitda margin can be defined as earnings before interest, taxes, depreciation and amortization as a portion of total revenue.

Upstream Bio EBITDA Margin 1971-1970 | UPB

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Upstream Bio ebitda margin from 1971 to 1970. Ebitda margin can be defined as earnings before interest, taxes, depreciation and amortization as a portion of total revenue.

Related Stocks
Company Name	Market Cap
Amgen (AMGN)	$172.8B
Vertex Pharmaceuticals (VRTX)	$124.7B
Regeneron Pharmaceuticals (REGN)	$109.2B
Gilead Sciences (GILD)	$108B
Bristol Myers Squibb (BMY)	$107.9B
CSL (CSLLY)	$97.9B
GSK (GSK)	$79.9B
Alnylam Pharmaceuticals (ALNY)	$38B
Argenex SE (ARGX)	$33.8B
Biogen (BIIB)	$27.7B
BioNTech SE (BNTX)	$26.6B
Illumina (ILMN)	$23.3B
BeiGene (BGNE)	$21.3B
Moderna (MRNA)	$20.8B
Genmab (GMAB)	$15.2B
BioMarin Pharmaceutical (BMRN)	$13.3B
Exact Sciences (EXAS)	$13.3B
Vaxcyte (PCVX)	$12.9B
Insmed (INSM)	$12.8B
Incyte (INCY)	$12.8B
Sarepta Therapeutics (SRPT)	$12.1B
Bio-Techne Corp (TECH)	$11.3B
QIAGEN (QGEN)	$9.8B
Bio-Rad Laboratories (BIO.B)	$9.3B
Roivant Sciences (ROIV)	$8.8B
Revolution Medicines (RVMD)	$8.4B
Intra-Cellular Therapies (ITCI)	$8.3B
Exelixis (EXEL)	$8.2B
Repligen (RGEN)	$8.2B
Ascendis Pharma (ASND)	$7.9B